Date 2020
Organisation Johnson & Johnson
Resource Type Insight
Language English

The global coronavirus pandemic has had a profound impact on how we live and work, requiring us to shift daily schedules, connect differently and adapt to new dynamics and scenarios.

Since the start of this crisis, Johnson & Johnson has mobilized to address critical needs of those around the world. This includes keeping its 132,000 employees safe, healthy and productive as the company works to develop an affordable, safe and effective vaccine that can be made available to the public on a not-for-profit basis for emergency pandemic use.

(Source: www.jnj.com

The Consumer Goods Forum Official Logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.